SSG
ESMC

Summit Securities Group’s Escalon Medical Corp ESMC Stock Holding History

Summit Securities Group’s Portfolio ESMC Stock Details ESMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-50
Closed – – 660
2013
Q4 		$0 Buy
+50
New +$81 ﹤0.01% 635

Other funds holding ESMC

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
KTC
Kistler-Tiffany Companies Berwyn, Pennsylvania $616M AUM 16.74% 1-Year Est. Return

Summit Securities Group's ESMC Position: Q1 2014 in Review

Summit Securities Group sold out of Escalon Medical Corp (ESMC) in Q1 2014, closing a stake of 50 shares.

Summit Securities Group first reported a position in ESMC in Q4 2013 and held it in 1 quarter. The position peaked at $0 in Q4 2013. 11 funds tracked by Wall St. Rank hold ESMC as of Q1 2014.

  • Summit Securities Group reported no remaining Escalon Medical Corp position as of Q1 2014 after selling out during the quarter.
  • Summit Securities Group sold 50 Escalon Medical Corp shares in Q1 2014.
  • Summit Securities Group first reported a position in Escalon Medical Corp in Q4 2013 and held it in 1 quarter.
  • Summit Securities Group's Escalon Medical Corp position peaked at $0 in Q4 2013.
  • 11 funds tracked by Wall St. Rank held Escalon Medical Corp as of Q1 2014.

Based on Summit Securities Group's 13F filing for Q1 2014, filed 17 Apr 2014.